Oldie but Goodie: Is Technetium-99m Still a Treasure Trove of Innovation for Medicine? A Patents Analysis (2000–2022)
Journal of Medicinal Chemistry · 13.04.2023 · 66 (7) · 4532-4547
DOI: 10.1021/acs.jmedchem.3c00148 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 03.04.2023. Verfasst von Mattia Riondato und 6 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS San Martino University Hospital, Largo R. Benzi, 10, 16132 Genova, Italy. Hauptthemen laut MEDLINE: Technetium, Radiopharmaceuticals. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Technetium-99m is the workhorse of diagnostic nuclear medicine. The aim of the work is to analyze the technetium-99m patents since 2000 to photograph its innovation. QUESTEL's ORBIT Intelligence system was used for the collection of technetium inventions disclosed in patents and patent applications in more than 96 countries in the period 2000-2022; 2768 patent documents were analyzed. Patent counting and analysis have shown that SPECT imaging using technetium-99m radiopharmaceuticals is still robust. The introduction of new technetium-99m radiopharmaceuticals into clinical routine goes beyond successful trials. In eastern economies, such as China and other emerging markets, patent applications are on the rise, while those in developed western countries are stagnating, with some exceptions for the United States. But despite the difficulties, academic and industrial research on these tracers remains essential for the development of nuclear medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- IRCCS San Martino University Hospital, Largo R. Benzi, 10, 16132 Genova, Italy.
- European and Italian Patent Attorney, Marchi & Partners S.r.l., Via V. Pisani 13, 20124 Milan, Italy.
- Department of Environmental and Prevention Sciences, University of Ferrara, Via L. Borsari, 46, 44121 Ferrara, Italy.
- Department of Translational Medicine, University of Ferrara, Via Fossato di Mortara, 70 c/o viale Eliporto, 44121 Ferrara, Italy.
- Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via L. Borsari, 46, 44121 Ferrara, Italy.
ORCID-Profile: Alessandra Boschi
Zitieren
APA
Riondato, M., Rigamonti, D., Martini, P., Cittanti, C., Boschi, A., Urso, L., & Uccelli, L. (2023). Oldie but Goodie: Is Technetium-99m Still a Treasure Trove of Innovation for Medicine? A Patents Analysis (2000–2022). Journal of Medicinal Chemistry, 66(7), 4532-4547. https://doi.org/10.1021/acs.jmedchem.3c00148
Vancouver
Riondato M, Rigamonti D, Martini P, Cittanti C, Boschi A, Urso L, et al. Oldie but Goodie: Is Technetium-99m Still a Treasure Trove of Innovation for Medicine? A Patents Analysis (2000–2022). Journal of Medicinal Chemistry. 2023;66(7):4532-4547. doi:10.1021/acs.jmedchem.3c00148
BibTeX
@article{Riondato2023,
author = {Riondato, Mattia and Rigamonti, Dorotea and Martini, Petra and Cittanti, Corrado and Boschi, Alessandra and Urso, Luca and Uccelli, Licia},
title = {Oldie but Goodie: Is Technetium-99m Still a Treasure Trove of Innovation for Medicine? A Patents Analysis (2000–2022)},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {7},
pages = {4532--4547},
doi = {10.1021/acs.jmedchem.3c00148}
}
EUVIMED